<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2">As filed with the Securities and
Exchange Commission on June 4, 2002</FONT>

<P align="right"><FONT size="2">Registration No.&nbsp;333-__________</FONT>
<p>
<HR noshade size="2" width="100%" align="left">

<P align="center"><FONT size="2"><B>SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></FONT>

<P>
<HR width="26%" align="center" size="1" noshade>
<P>


<P align="center"><FONT size="2"><B>FORM S-8<BR>
REGISTRATION STATEMENT UNDER<BR>
THE SECURITIES ACT OF 1933</B></FONT>

<P>
<HR width="26%" align="center" size="1" noshade>
<P>


<P align="center"><FONT size="2"><B>PROXYMED, INC.</B><BR>
(Exact name of registrant as specified in its charter)</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
        <TD width="51%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="44%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2"><B>Florida</B><BR>
(State or other jurisdiction<BR>
of incorporation or organization)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
<B>65-0202059</B><BR>
(I.R.S. Employer Identification No.)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2"><B>2555 Davie Road, Suite&nbsp;110<BR>
Ft. Lauderdale, Florida 33317<BR>
(954)&nbsp;473-1001</B><BR>
(Address, including zip code, and telephone number, including area code,<BR>
of registrant&#146;s principal executive offices)</FONT>

<P align="center"><FONT size="2"><B>PROXYMED 1999 STOCK OPTION PLAN<BR>
PROXYMED 2000 STOCK OPTION PLAN<BR>
PROXYMED AMENDED 2000 1/2 STOCK OPTION PLAN<BR>
PROXYMED 2001 STOCK OPTION PLAN<BR>
PROXYMED 2002 STOCK OPTION PLAN<BR>
PROXYMED EMPLOYEE NON-QUALIFIED STOCK OPTION AGREEMENTS</B><BR>
(Full titles of the plans)</FONT>

<P align="center"><FONT size="2"><B>Michael K. Hoover<BR>
Chief Executive Officer<BR>
ProxyMed, Inc.<BR>
2555 Davie Road, Suite&nbsp;110<BR>
Fort Lauderdale, Florida 33317<BR>
(954)&nbsp;473-1001</B><BR>
(Name, address, including zip code, and telephone number,<BR>
including area code, of agent for service)</FONT>

<P align="center"><FONT size="2"><I><B>Copies of communications
to:</B></I></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
        <TD width="51%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="44%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2"><B>Rafael G. Rodriguez<BR>
In-House Counsel<BR>
ProxyMed, Inc.<BR>
2555 Davie Road, Suite&nbsp;110<BR>
Fort Lauderdale, Florida 33317<BR>
(954)&nbsp;473-1001</B></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
<B>Steven Sonberg, Esq.<BR>
Holland &#038; Knight LLP<BR>
701 Brickell Avenue<BR>
Suite&nbsp;3000<BR>
Miami, Florida 33131<BR>
(305)&nbsp;374-8500</B></FONT></TD>
</TR>
</TABLE>
</CENTER>


<P align="center"><FONT size="2"><B>CALCULATION OF REGISTRATION FEE</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="3%">&nbsp;</TD>
        <TD width="34%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="11%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="11%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="4%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="6%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="6%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed Maximum</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed Maximum</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount of</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center" colspan="2"><FONT size="1"><B>Title of Each Class of</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount to</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Offering Price</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Aggregate Offering</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Registration</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center" colspan="2"><FONT size="1"><B>Securities to be Registered</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>be Registered(1)</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Per Share(4)</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Price</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center" colspan="3"><FONT size="1"><B>Fee</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD colspan="2"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD colspan="3"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom" bgcolor="#eeeeee">
        <TD colspan="2"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Common Stock ($.001 par value)</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD colspan="3" align="center"><FONT size="2">1,178,333 shares(2)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">19.66</FONT></TD>
        <TD nowrap><FONT size="2">(5)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD nowrap align="right"><FONT size="2">23,160,142</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">2,131</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD colspan="2"><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Common Stock ($.001 par value)</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD colspan="3" align="center"><FONT size="2">414,887 shares(3)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD nowrap align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">24.31</FONT></TD>
        <TD nowrap><FONT size="2">(6)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">10,084,008</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">928</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom" bgcolor="#eeeeee">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT size="2">Total</FONT></DIV></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD colspan="3" align="center"><FONT size="2">1,593,220 shares</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">&#151;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">33,244,150</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right"><FONT size="2">$</FONT></TD>
        <TD align="right"><FONT size="2">3,059</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P>
<HR size="1" width="18%" align="left" noshade>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(1)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Pursuant to Rule&nbsp;416 under the Securities Act of 1933, as amended (the
&#147;Securities Act&#148;), the number of shares of common stock, par value $.001
per share (the &#147;Common Stock&#148;), of ProxyMed, Inc. (the &#147;Company&#148;) being
registered shall be adjusted to include any additional shares which may
become issuable as a result of stock splits, stock dividends or similar
transactions. In addition, pursuant to Rule&nbsp;416(c) under the Securities
Act, this registration statement also covers an indeterminate amount of
interests to be offered or sold pursuant to the employee benefit plan(s)
described herein.</FONT></TD>
</TR>
<TR>

        <TD><FONT size="2">&nbsp;</FONT></TD>
</tr>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(2)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Includes (i)&nbsp;23,333.33 shares issuable under the ProxyMed 1999 Stock Option
Plan, (ii)&nbsp;20,000 shares issuable under the ProxyMed 2000 Stock Option
Plan, (iii)&nbsp;201,666.67 shares issuable under the ProxyMed Amended 2000 1/2
Stock Option Plan; (iv)&nbsp;333,333.33 shares issuable under the ProxyMed 2001
Stock Option Plan; and (v)&nbsp;600,000 shares issuable under the ProxyMed 2002
Stock Option Plan.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(3)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Includes shares of Common Stock underlying non-qualified stock options
granted to employees not pursuant to any stock option plan.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(4)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Estimated solely for the purpose of calculating the registration fee and
computed in accordance with Rule&nbsp;457(h) and Rule&nbsp;457(c) under the
Securities Act.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(5)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Computed on the basis of the average of the high and low prices of the
Common Stock reported on the Nasdaq National Market on June&nbsp;3, 2002.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
      <TD width="1%" align="left" nowrap><FONT size="2">(6)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Based on the weighted average exercise price (rounded to the nearest cent)
at which the shares will be issued.</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>




<P align="center"><FONT size="2"><B>EXPLANATORY NOTE</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This registration statement on Form&nbsp;S-8 (this &#147;Registration Statement&#148;)
has been prepared in accordance with the requirements of Form&nbsp;S-8 and is
intended to be used to register shares to be issued and sold pursuant to the
ProxyMed 1999 Stock Option Plan, the ProxyMed 2000 Stock Option Plan, the
ProxyMed Amended 2000 1/2 Stock Option Plan, the ProxyMed 2001 Stock Option
Plan, and the ProxyMed 2002 Stock Option Plan, and other ProxyMed Employee
Non-Qualified Stock Option Agreements.
</FONT>
<P align="center"><FONT size="2">3</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2"><B>PART II</B></FONT>

<P align="center"><FONT size="2"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></FONT>

<P align="left"><FONT size="2"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents filed by the Company with the SEC are hereby
incorporated herein by reference:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(1)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Annual Report on Form&nbsp;10-K for the year ended
December&nbsp;31, 2001 filed on April&nbsp;1, 2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(2)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter
ended March&nbsp;31, 2002 filed on May&nbsp;15, 2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(3)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K filed on January&nbsp;10,
2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(4)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K filed on February&nbsp;20,
2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(5)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K filed on March&nbsp;29,
2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(6)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K filed on April&nbsp;8,
2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(7)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K filed on April&nbsp;30,
2002;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(8)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K filed on May&nbsp;7, 2002;
and</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(9)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">The description of the Company&#146;s Common Stock contained in our
Registration Statement on Form&nbsp;8-A declared effective on
August&nbsp;5, 1993, including any other amendment or report filed
for the purpose of updating such information.</FONT></TD>
</TR>
</TABLE>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All documents subsequently filed by the registrant pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended
(the &#147;Exchange Act&#148;), prior to the filing of a post-effective amendment which
indicates that all shares of Common Stock being offered hereby have been sold or
which de-registers all shares of Common Stock then remaining unsold, shall be
deemed incorporated by reference in this Registration Statement and to be a part
hereof from the date of filing of such documents.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any statement in a document incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for purposes of
this prospectus to the extent that a statement contained herein or in any other
subsequently filed document, which also is or is deemed to be incorporated by
reference herein, modifies or replaces such statement. Any statement so modified
or superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this prospectus.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant undertakes to provide without charge to each person,
including any beneficial owner, to whom this prospectus is delivered, upon
written or oral request of such person, a copy of any and all information that
has been incorporated by reference in this prospectus (not including exhibits to
the information that is incorporated by reference, unless such exhibits are
specifically incorporated by reference into the information that this prospectus
incorporates). Such request should be directed to: ProxyMed, Inc., 2555 Davie
Road, Suite&nbsp;110, Fort Lauderdale, Florida 33317, Attn: Corporate Secretary,
Telephone: (954)&nbsp;473-1001, ext. 300.
</FONT>
<P align="left"><FONT size="2"><B>Item&nbsp;4. Description of Securities.</B></FONT>

<P><FONT size="2">Not applicable.
</FONT>
<P align="center"><FONT size="2">4</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="left"><FONT size="2"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B></FONT>

<P><FONT size="2">Not applicable.
</FONT>
<P align="left"><FONT size="2"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B></FONT>

<P><FONT size="2">Section&nbsp;607.0850(1) of the Florida Business Corporation Act empowers a Florida
corporation to indemnify any person, who was or is a party to any proceeding
(other than an action by a corporation, or in the right of such a corporation) by reason of the
fact that such person is or was a director, officer, employee, or agent of such
corporation, or is or was serving at the request of such corporation as a
director, officer, employee, or agent of another corporation, partnership, joint
venture, trust, or other enterprise, against liability incurred in connection
with such proceeding, including an appeal thereof. The foregoing applies only if
such person acted in good faith and in a manner reasonably believed to be in, or
not opposed to, the best interests of the corporation, and, with respect to any
criminal action or proceeding, such person had no reasonable cause to believe
his conduct was unlawful.
</FONT>


<P><FONT size="2">In an action by, or in the right of, such
corporation to procure a judgment in its favor by reason of the fact
that such a person is or was a director, officer, employee, or agent
of such corporation, or is or was serving at the request of such
corporation as a director, officer, employee, or agent of another
corporation, partnership, joint venture, trust, or other enterprise,
Section&nbsp;607.0850(2) of the Florida Business Corporation Act
empowers a Florida corporation to indemnify such person against
expenses and amounts paid in settlement not exceeding, in the judgement
of the board of directors, the estimated expense of litigating the
proceeding to conclusion, actually and reasonably incurred by such
person in connection with the defense or settlement of such
proceeding, including any appeal thereof. The foregoing applies only
if such person acted in good faith and in a manner such person
believed to be in, or not opposed to, the best interests of the
corporation. However, no indemnification is permitted in respect of
any claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation, unless and to the extent
the court in which such action or suit was brought or other court of
competent jurisdiction shall determine upon application that, in view
of all circumstances of the case, such person is fairly and
reasonably entitled to indemnity for such expenses as the court shall
deem proper.
</FONT>
<P><FONT size="2">To the extent such person has been successful on the merits or otherwise in
defense of any action referred to above, or in defense of any claim, issue or
matter therein, the corporation must indemnify such person against expenses,
including counsel (including those for appeal) fees actually and reasonably
incurred by such person in connection therewith. The indemnification and
advancement of expenses provided for in, or granted pursuant to, Section
607.0850 is not exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled under the articles of
incorporation of the corporation or any by-law, agreement, vote of shareholders
or disinterested directors, or otherwise. Section&nbsp;607.0850 also provides that a
corporation may maintain insurance against liabilities for which indemnification
is not expressly provided by the statute.
</FONT>
<P><FONT size="2">Article&nbsp;VII of the Company&#146;s Restated Articles of Incorporation and Article&nbsp;VII
of the Company&#146;s By-Laws provide for indemnification of the directors, officers,
employees and agents of the Company (including advancement of expenses) to the
fullest extent permitted under Florida law. In addition, the Company has
contractually agreed to indemnify its directors and executive
officers, as well as certain non-executive officers, to the fullest
extent permitted under Florida law.
</FONT>
<P align="center"><FONT size="2">5</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to directors, officers or persons controlling the Company as
disclosed above, the Company has been informed that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable. In the event
that a claim for indemnification against such liabilities (other than the
payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
</FONT>
<P align="left"><FONT size="2"><B>Item&nbsp;7. Exemption From Registration Claimed.</B></FONT>

<P><FONT size="2">Not applicable.
</FONT>
<P align="left"><FONT size="2"><B>Item&nbsp;8. Exhibits.</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
        <TD width="19%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="76%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2"><B>Exhibit&nbsp;No.</B></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<B>Description of Documents</B></FONT></TD>
</TR>
<TR>
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<HR size="1" noshade></FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Opinion of Holland &#038; Knight LLP</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 1999 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 2000 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed Amended 2000 1/2Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 2001 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 2002 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.6</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Form of Employee Non-Qualified Stock Option
Agreement</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Holland &#038; Knight LLP (included in
Exhibit&nbsp;5)</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of PricewaterhouseCoopers LLP</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Cerqueda, Morgan, Gault &#038; Collins,
LLP (formerly Pate, Cerqueda, Morgan &#038; Gault,
LLP)</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">24.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Power of Attorney (included in the signature
page hereto)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">6</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="left"><FONT size="2"><B>Item&nbsp;9. Undertakings.</B></FONT>

<P><FONT size="2">The undersigned registrant hereby undertakes:
</FONT>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">(1)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(i)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">To include any prospectus required by Section&nbsp;10(a)(3) of the
Securities Act;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(ii)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">To reflect in the prospectus any facts or events arising after
the effective date of this Registration Statement (or the most
recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the
information set forth in this Registration Statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule&nbsp;424(b)
if, in the aggregate, the changes in volume and price represent
no more than 20&nbsp;percent change in the maximum aggregate
offering price set forth in the Calculation of Registration Fee
table in the effective Registration Statement; and</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">(iii)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="93%"><FONT size="2">To include any material information with respect to the plan of
distribution not previously disclosed in this Registration
Statement or any material change to such information in this
Registration Statement;</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">(2)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be
deemed to be the initial BONA FIDE offering thereof.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">(3)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the
termination of the offering.</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">(4)</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">That, for purposes of determining any liability under the Securities
Act, each filing of the registrant&#146;s annual report pursuant to Section
13(a) or Section&nbsp;15(d) of the Exchange Act (and, where applicable,
each filing of the annual report of the employee benefit plans
pursuant to Section&nbsp;15(d) of the Exchange Act) that is incorporated by
reference in this Registration Statement shall be deemed to be a new
registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the
initial BONA FIDE offering thereof.</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">7</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>




<P align="center"><FONT size="2"><B>SIGNATURES</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form&nbsp;S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Fort Lauderdale, State of Florida, on
June&nbsp;4, 2002.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="49%">&nbsp;</TD>
        <TD width="2%">&nbsp;</TD>
        <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
PROXYMED, INC.</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
By: /s/ Judson E. Schmid</FONT></TD>
</TR>
<TR>
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<HR noshade size="1" width="50%" align="left"></FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Judson E. Schmid<br>
Executive Vice President and<br>
Chief Financial Officer</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Michael K. Hoover and Judson E. Schmid,
and each of them, his true and lawful attorney-in-fact and agent, with full
power of substitution, for him and in his name, in any and all capacities, to
sign all amendments (including post-effective amendments) to the Registration
Statement to which this power of attorney is attached, and to file all those
amendments and all exhibits to them and other documents to be filed in
connection with them, including any registration statement pursuant to Rule&nbsp;462
under Securities Act of 1933, with the Securities and Exchange Commission.
</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="34%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="43%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="13%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2"><B>Signatures</B></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<B>Title</B>
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2"><B>Date</B></FONT></TD>
</TR>
<TR>
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<HR size="1" noshade>
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><HR size="1" noshade></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Michael K. Hoover
<HR size="1" noshade>
Michael K. Hoover</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Chairman of the Board, Chief
Executive Officer and Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Edwin M. Cooperman
<HR size="1" noshade>
Edwin M. Cooperman</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Gerald B. Cramer
<HR size="1" noshade>
Gerald B. Cramer</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Michael S. Falk
<HR size="1" noshade>
Michael S. Falk</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Thomas E. Hodapp
<HR size="1" noshade>
Thomas E. Hodapp</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Braden R. Kelly
<HR size="1" noshade>
Braden R. Kelly</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
<tr><td>&nbsp;</td></tr>
<TR>
        <TD valign="top"><FONT size="2">/s/ Eugene R. Terry
<HR size="1" noshade>
Eugene R. Terry</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">June 4, 2002</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">8</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="2"><B>INDEX TO EXHIBITS</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="85%">
<TR valign="bottom">
        <TD width="13%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="82%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2"><B>Number</B></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<B>Description of Documents</B></FONT></TD>
</TR>
<TR>
        <TD valign="top"><HR size="1" noshade></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
<HR size="1" noshade></FONT></TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Opinion of Holland &#038; Knight LLP</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 1999 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 2000 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed Amended 2000 1/2Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.4</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 2001 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
ProxyMed 2002 Stock Option Plan</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">10.6</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Form of Employee Non-Qualified Stock Option
Agreement</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Holland &#038; Knight LLP (included in
Exhibit&nbsp;5)</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.2</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of PricewaterhouseCoopers LLP</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">23.3</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Consent of Cerqueda, Morgan, Gault &#038; Collins,
LLP (formerly Pate, Cerqueda, Morgan &#038; Gault,
LLP)</FONT></TD>
</TR>
<TR><TD><TR><TD><TR><TD><TR><TD>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">24.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Power of Attorney (included in the signature
page hereto)</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P align="center"><FONT size="2">9</FONT>




</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g76645sv8.htm", "description": "PROXYMED, INC. FORM S-8", "secsgml_size_bytes": 44777}]
{"company-data": {"conformed-name": "PROXYMED INC /FT LAUDERDALE/", "cik": "0000906337", "assigned-sic": "7374", "irs-number": "650202059", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-89764", "film-number": "02670127"}, "business-address": {"street1": "2555 DAVIE ROAD", "street2": "SUITE 110", "city": "FORT LAUDERDALE", "state": "FL", "zip": "33317-7424", "phone": "9544731001"}, "mail-address": {"street1": "2555 DAVIE ROAD", "street2": "SUITE 110", "city": "FT LAUDERDALE", "state": "FL", "zip": "33317"}, "former-company": {"former-conformed-name": "HMO PHARMACY INC", "date-changed": "19930601"}}
sv8
As filed with the Securities and
Exchange Commission on June 4, 2002
Registration No. 333-__________
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
PROXYMED, INC.
(Exact name of registrant as specified in its charter)
Florida
(State or other jurisdiction
of incorporation or organization)
65-0202059
(I.R.S. Employer Identification No.)
2555 Davie Road, Suite 110
Ft. Lauderdale, Florida 33317
(954) 473-1001
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
PROXYMED 1999 STOCK OPTION PLAN
PROXYMED 2000 STOCK OPTION PLAN
PROXYMED AMENDED 2000 1/2 STOCK OPTION PLAN
PROXYMED 2001 STOCK OPTION PLAN
PROXYMED 2002 STOCK OPTION PLAN
PROXYMED EMPLOYEE NON-QUALIFIED STOCK OPTION AGREEMENTS
(Full titles of the plans)
Michael K. Hoover
Chief Executive Officer
ProxyMed, Inc.
2555 Davie Road, Suite 110
Fort Lauderdale, Florida 33317
(954) 473-1001
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
Copies of communications
to:
Rafael G. Rodriguez
In-House Counsel
ProxyMed, Inc.
2555 Davie Road, Suite 110
Fort Lauderdale, Florida 33317
(954) 473-1001
Steven Sonberg, Esq.
Holland & Knight LLP
701 Brickell Avenue
Suite 3000
Miami, Florida 33131
(305) 374-8500
CALCULATION OF REGISTRATION FEE
Proposed Maximum
Proposed Maximum
Amount of
Title of Each Class of
Amount to
Offering Price
Aggregate Offering
Registration
Securities to be Registered
be Registered(1)
Per Share(4)
Price
Fee
Common Stock ($.001 par value)
1,178,333 shares(2)
$
19.66
(5)
$
23,160,142
$
2,131
Common Stock ($.001 par value)
414,887 shares(3)
$
24.31
(6)
$
10,084,008
$
928
Total
1,593,220 shares
—
$
33,244,150
$
3,059
(1)
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the
"Securities Act"), the number of shares of common stock, par value $.001
per share (the "Common Stock"), of ProxyMed, Inc. (the "Company") being
registered shall be adjusted to include any additional shares which may
become issuable as a result of stock splits, stock dividends or similar
transactions. In addition, pursuant to Rule 416(c) under the Securities
Act, this registration statement also covers an indeterminate amount of
interests to be offered or sold pursuant to the employee benefit plan(s)
described herein.
(2)
Includes (i) 23,333.33 shares issuable under the ProxyMed 1999 Stock Option
Plan, (ii) 20,000 shares issuable under the ProxyMed 2000 Stock Option
Plan, (iii) 201,666.67 shares issuable under the ProxyMed Amended 2000 1/2
Stock Option Plan; (iv) 333,333.33 shares issuable under the ProxyMed 2001
Stock Option Plan; and (v) 600,000 shares issuable under the ProxyMed 2002
Stock Option Plan.
(3)
Includes shares of Common Stock underlying non-qualified stock options
granted to employees not pursuant to any stock option plan.
(4)
Estimated solely for the purpose of calculating the registration fee and
computed in accordance with Rule 457(h) and Rule 457(c) under the
Securities Act.
(5)
Computed on the basis of the average of the high and low prices of the
Common Stock reported on the Nasdaq National Market on June 3, 2002.
(6)
Based on the weighted average exercise price (rounded to the nearest cent)
at which the shares will be issued.
2
EXPLANATORY NOTE
This registration statement on Form S-8 (this "Registration Statement")
has been prepared in accordance with the requirements of Form S-8 and is
intended to be used to register shares to be issued and sold pursuant to the
ProxyMed 1999 Stock Option Plan, the ProxyMed 2000 Stock Option Plan, the
ProxyMed Amended 2000 1/2 Stock Option Plan, the ProxyMed 2001 Stock Option
Plan, and the ProxyMed 2002 Stock Option Plan, and other ProxyMed Employee
Non-Qualified Stock Option Agreements.
3
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed by the Company with the SEC are hereby
incorporated herein by reference:
(1)
The Company's Annual Report on Form 10-K for the year ended
December 31, 2001 filed on April 1, 2002;
(2)
The Company's Quarterly Report on Form 10-Q for the quarter
ended March 31, 2002 filed on May 15, 2002;
(3)
The Company's Current Report on Form 8-K filed on January 10,
2002;
(4)
The Company's Current Report on Form 8-K filed on February 20,
2002;
(5)
The Company's Current Report on Form 8-K filed on March 29,
2002;
(6)
The Company's Current Report on Form 8-K filed on April 8,
2002;
(7)
The Company's Current Report on Form 8-K filed on April 30,
2002;
(8)
The Company's Current Report on Form 8-K filed on May 7, 2002;
and
(9)
The description of the Company's Common Stock contained in our
Registration Statement on Form 8-A declared effective on
August 5, 1993, including any other amendment or report filed
for the purpose of updating such information.
All documents subsequently filed by the registrant pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), prior to the filing of a post-effective amendment which
indicates that all shares of Common Stock being offered hereby have been sold or
which de-registers all shares of Common Stock then remaining unsold, shall be
deemed incorporated by reference in this Registration Statement and to be a part
hereof from the date of filing of such documents.
Any statement in a document incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for purposes of
this prospectus to the extent that a statement contained herein or in any other
subsequently filed document, which also is or is deemed to be incorporated by
reference herein, modifies or replaces such statement. Any statement so modified
or superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this prospectus.
The registrant undertakes to provide without charge to each person,
including any beneficial owner, to whom this prospectus is delivered, upon
written or oral request of such person, a copy of any and all information that
has been incorporated by reference in this prospectus (not including exhibits to
the information that is incorporated by reference, unless such exhibits are
specifically incorporated by reference into the information that this prospectus
incorporates). Such request should be directed to: ProxyMed, Inc., 2555 Davie
Road, Suite 110, Fort Lauderdale, Florida 33317, Attn: Corporate Secretary,
Telephone: (954) 473-1001, ext. 300.
Item 4. Description of Securities.
Not applicable.
4
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
Section 607.0850(1) of the Florida Business Corporation Act empowers a Florida
corporation to indemnify any person, who was or is a party to any proceeding
(other than an action by a corporation, or in the right of such a corporation) by reason of the
fact that such person is or was a director, officer, employee, or agent of such
corporation, or is or was serving at the request of such corporation as a
director, officer, employee, or agent of another corporation, partnership, joint
venture, trust, or other enterprise, against liability incurred in connection
with such proceeding, including an appeal thereof. The foregoing applies only if
such person acted in good faith and in a manner reasonably believed to be in, or
not opposed to, the best interests of the corporation, and, with respect to any
criminal action or proceeding, such person had no reasonable cause to believe
his conduct was unlawful.
In an action by, or in the right of, such
corporation to procure a judgment in its favor by reason of the fact
that such a person is or was a director, officer, employee, or agent
of such corporation, or is or was serving at the request of such
corporation as a director, officer, employee, or agent of another
corporation, partnership, joint venture, trust, or other enterprise,
Section 607.0850(2) of the Florida Business Corporation Act
empowers a Florida corporation to indemnify such person against
expenses and amounts paid in settlement not exceeding, in the judgement
of the board of directors, the estimated expense of litigating the
proceeding to conclusion, actually and reasonably incurred by such
person in connection with the defense or settlement of such
proceeding, including any appeal thereof. The foregoing applies only
if such person acted in good faith and in a manner such person
believed to be in, or not opposed to, the best interests of the
corporation. However, no indemnification is permitted in respect of
any claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation, unless and to the extent
the court in which such action or suit was brought or other court of
competent jurisdiction shall determine upon application that, in view
of all circumstances of the case, such person is fairly and
reasonably entitled to indemnity for such expenses as the court shall
deem proper.
To the extent such person has been successful on the merits or otherwise in
defense of any action referred to above, or in defense of any claim, issue or
matter therein, the corporation must indemnify such person against expenses,
including counsel (including those for appeal) fees actually and reasonably
incurred by such person in connection therewith. The indemnification and
advancement of expenses provided for in, or granted pursuant to, Section
607.0850 is not exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled under the articles of
incorporation of the corporation or any by-law, agreement, vote of shareholders
or disinterested directors, or otherwise. Section 607.0850 also provides that a
corporation may maintain insurance against liabilities for which indemnification
is not expressly provided by the statute.
Article VII of the Company's Restated Articles of Incorporation and Article VII
of the Company's By-Laws provide for indemnification of the directors, officers,
employees and agents of the Company (including advancement of expenses) to the
fullest extent permitted under Florida law. In addition, the Company has
contractually agreed to indemnify its directors and executive
officers, as well as certain non-executive officers, to the fullest
extent permitted under Florida law.
5
Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to directors, officers or persons controlling the Company as
disclosed above, the Company has been informed that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable. In the event
that a claim for indemnification against such liabilities (other than the
payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
Item 7. Exemption From Registration Claimed.
Not applicable.
Item 8. Exhibits.
Exhibit No.
Description of Documents
5
Opinion of Holland & Knight LLP
10.1
ProxyMed 1999 Stock Option Plan
10.2
ProxyMed 2000 Stock Option Plan
10.3
ProxyMed Amended 2000 1/2Stock Option Plan
10.4
ProxyMed 2001 Stock Option Plan
10.5
ProxyMed 2002 Stock Option Plan
10.6
Form of Employee Non-Qualified Stock Option
Agreement
23.1
Consent of Holland & Knight LLP (included in
Exhibit 5)
23.2
Consent of PricewaterhouseCoopers LLP
23.3
Consent of Cerqueda, Morgan, Gault & Collins,
LLP (formerly Pate, Cerqueda, Morgan & Gault,
LLP)
24.1
Power of Attorney (included in the signature
page hereto)
6
Item 9. Undertakings.
The undersigned registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
(i)
To include any prospectus required by Section 10(a)(3) of the
Securities Act;
(ii)
To reflect in the prospectus any facts or events arising after
the effective date of this Registration Statement (or the most
recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the
information set forth in this Registration Statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b)
if, in the aggregate, the changes in volume and price represent
no more than 20 percent change in the maximum aggregate
offering price set forth in the Calculation of Registration Fee
table in the effective Registration Statement; and
(iii)
To include any material information with respect to the plan of
distribution not previously disclosed in this Registration
Statement or any material change to such information in this
Registration Statement;
(2)
That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be
deemed to be the initial BONA FIDE offering thereof.
(3)
To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the
termination of the offering.
(4)
That, for purposes of determining any liability under the Securities
Act, each filing of the registrant's annual report pursuant to Section
13(a) or Section 15(d) of the Exchange Act (and, where applicable,
each filing of the annual report of the employee benefit plans
pursuant to Section 15(d) of the Exchange Act) that is incorporated by
reference in this Registration Statement shall be deemed to be a new
registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the
initial BONA FIDE offering thereof.
7
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Fort Lauderdale, State of Florida, on
June 4, 2002.
PROXYMED, INC.
By: /s/ Judson E. Schmid
Judson E. Schmid
Executive Vice President and
Chief Financial Officer
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Michael K. Hoover and Judson E. Schmid,
and each of them, his true and lawful attorney-in-fact and agent, with full
power of substitution, for him and in his name, in any and all capacities, to
sign all amendments (including post-effective amendments) to the Registration
Statement to which this power of attorney is attached, and to file all those
amendments and all exhibits to them and other documents to be filed in
connection with them, including any registration statement pursuant to Rule 462
under Securities Act of 1933, with the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
Signatures
Title
Date
/s/ Michael K. Hoover
Michael K. Hoover
Chairman of the Board, Chief
Executive Officer and Director
June 4, 2002
/s/ Edwin M. Cooperman
Edwin M. Cooperman
Director
June 4, 2002
/s/ Gerald B. Cramer
Gerald B. Cramer
Director
June 4, 2002
/s/ Michael S. Falk
Michael S. Falk
Director
June 4, 2002
/s/ Thomas E. Hodapp
Thomas E. Hodapp
Director
June 4, 2002
/s/ Braden R. Kelly
Braden R. Kelly
Director
June 4, 2002
/s/ Eugene R. Terry
Eugene R. Terry
Director
June 4, 2002
8
INDEX TO EXHIBITS
Number
Description of Documents
5
Opinion of Holland & Knight LLP
10.1
ProxyMed 1999 Stock Option Plan
10.2
ProxyMed 2000 Stock Option Plan
10.3
ProxyMed Amended 2000 1/2Stock Option Plan
10.4
ProxyMed 2001 Stock Option Plan
10.5
ProxyMed 2002 Stock Option Plan
10.6
Form of Employee Non-Qualified Stock Option
Agreement
23.1
Consent of Holland & Knight LLP (included in
Exhibit 5)
23.2
Consent of PricewaterhouseCoopers LLP
23.3
Consent of Cerqueda, Morgan, Gault & Collins,
LLP (formerly Pate, Cerqueda, Morgan & Gault,
LLP)
24.1
Power of Attorney (included in the signature
page hereto)
9